Radioimmunoassay: Review of basic principles

https://doi.org/10.1016/S0001-2998(75)80028-6Get rights and content

The development of radioimmunoassay by the late Solomon A. Berson and Rosalyn S. Yalow during the late 1950s represents a milestone in the history of the application of radionuclide methodology to biology and to medical investigation and practice. The method offers a technique to assay materials otherwise unmeasureable or detectable only with difficulty. Radioimmunoassay is based upon the competition between labeled and unlabeled antigen for specific antibody sites, forming antigen-antibody complexes. This reaction is described by the expression

At equilibrium, the radioactive complex (bound) is separated from the radioactive antigen (free). The B/F ratio is dependent upon the amount of nonradioactive antigen. Antigen concentration in unknown samples is determined by comparing the B/F ratio to the B/F ratios obtained by incubating varying amounts of known nonradioactive antigen with the same amount of antibody as in the unknown sample under similar assay conditions. Sensitivity of the order of 10−12 moles/liter maybe achieved through the preparation and use of a labeled antigen of high specific activity and the production and selection of antisera with appropriately high affinity constants. Specificity is dependent upon the ability of the antiserum to recognize subtle structural features of the antigen molecule. The ability to conveniently assay large numbers of samples with good precision has led to the application of this technique to quantitate substances (such as steroids) already measurable but by more cumbersome methods. Since the initial description of competitive binding radioassay techniques, there have been numerous contributions to its further development, refinement, and application. This article reviews the conception and development of this invaluable contribution to our understanding of health and disease.

References (62)

  • RothenbergS.P.

    Application of competitive ligand binding for the radioassay of vitamin B12 and folic acid

    Metabolism

    (1973)
  • ConwayT.P. et al.

    Competitive ligand-binding radioassays for serum proteins

    Metabolism

    (1973)
  • WalshJ.G.

    Detection of virus antigen: Hepatitis B antigen

    Metabolism

    (1973)
  • UlickS.

    Application of radioimmunoassay to the renin-angiotensin system and to aldosterone

    Metabolism

    (1973)
  • WeintraubB.D. et al.

    Competitive radioassay and “specific” tumor markers

    Metabolism

    (1973)
  • SteinerA.L.

    Application of competitive ligand-binding radioassay to the nucleotides

    Metabolism

    (1973)
  • ButlerV.P.

    Radioimmunoassay and competitive binding radioassay methods for the measurements of drugs

    Metabolism

    (1973)
  • BersonS.A.

    Introduction to symposium on radioimmunoassay, in Protein and Polypeptide Hormones

  • BersonS.A. et al.

    Insulin I-131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects

    J Clin Invest

    (1956)
  • BersonS.A. et al.

    Assay of plasma insulin in human subjects by immunologic methods

    Nature

    (1954)
  • BersonS.A. et al.

    Immunoassay of endogenous plasma insulin in man

    J Clin Invest

    (1960)
  • GlickS.M. et al.

    Immunoassay of growth hormone in plasma

    Nature

    (1963)
  • GlickS.M. et al.

    The regulation of growth hormone secretion

  • BersonS.A. et al.

    Immunoassay of bovine and human parathyroid hormone

  • YalowR.S. et al.

    Radioimmunoassay of human plasma ACTH

    J Clin Endocrinol Metab

    (1964)
  • BersonS.A. et al.

    Radioimmunoassay of ACTH in plasma

    J Clin Invest

    (1968)
  • WalshJ.G. et al.

    Detection of Australia antigen and antibody using radioimmunoassay techniques

    J Infect Dis

    (1970)
  • BersonS.A. et al.

    Quantitative aspects of reaction between insulin and insulin binding antibody

    J Clin Invest

    (1959)
  • BersonS.A. et al.

    Species-specificity of human anti-beef, pork insulin serum

    J Clin Invest

    (1959)
  • YalowR.S. et al.

    Immunoassay of plasma insulin in man

    Diabetes

    (1961)
  • Cited by (76)

    • Quick detection and confirmation of microbes in food and water

      2022, Present Knowledge in Food Safety: A Risk-Based Approach through the Food Chain
    • Progress in cancer biomarkers monitoring strategies using graphene modified support materials

      2020, Talanta
      Citation Excerpt :

      Therefore, immunosensors which employ specific interaction of antigen with antibodies are getting increasingly popular in the clinical applications because of their ease of miniaturization and low cost. As a result, several immunoassay methods including enzyme-linked immunosorbent assay (ELISA) [16,17], fluorescence immunoassay [18,19], chemiluminescence immunoassay [20], radioimmunoassay [21], electrophoretic immunoassay [22], mass spectrometric immunoassay [23,24], and polymerase chain reaction assay [25] have been tested on the clinical serum sample analysis. Among variety of immunoassay techniques, electrochemical immunoassays have emerged as an excellent platform for tumor marker detection owing the advantages such as high sensitivity with antibody labeling, low cost, simple instrumentation, and easy portability.

    View all citing articles on Scopus
    *

    From the André Meyer Department of Physics (Nuclear Medicine), The Mount Sinai Hospital, New York, N. Y.

    View full text